$0.3647
0.0147[4.20%]
Last update: 12:26PM Get Real Time Here
Latest News for BiomX Stock (AMEX:PHGE)
BiomX Stock (AMEX: PHGE)
Categories: All
Wednesday, April 24, 2024
Monday, April 22, 2024
Thursday, April 04, 2024
Wednesday, April 03, 2024
- BiomX Q4 EPS $(0.08) Up From $(0.20) YoYBenzinga Newsdesk - Apr 3, 2024, 11:26PM
- HC Wainwright & Co. Reiterates Buy on BiomX, Maintains $2 Price TargetBenzinga Newsdesk - Apr 3, 2024, 11:39AM
- BiomX's 2023 Cash Balance, Short-Term Deposits And Restricted Cash Of $15.9M And Concurrent $50M Financing Is Expected To Provide Cash Runway Into 2025Benzinga Newsdesk - Apr 3, 2024, 6:37AM
- BiomX FY EPS $(0.51) Up From $(0.95) YoYBenzinga Newsdesk - Apr 3, 2024, 6:35AM
- Earnings Scheduled For April 3, 2024Benzinga Insights - Apr 3, 2024, 5:36AM
Thursday, March 28, 2024
Friday, March 08, 2024
Wednesday, March 06, 2024
- Why BiomX Stock Is Surging TodayErica Kollmann - Mar 6, 2024, 10:12AM
- BiomX shares are trading higher after the company announced that it has entered into a definitive merger agreement with Adaptive Phage Therapeutics and a concurrent $50 million in financing.Benzinga Newsdesk - Mar 6, 2024, 10:09AM
- BiomX Enters Merger Agreement With Adaptive Phage Therapeutics n Stock-For-Stock Transaction And Concurrent $50 Million Private Placement Financing; Former Stockholders Of BiomX Will Own Approximately 55% And The Former Stockholders Of APT Will Own Approximately 45% Of The Consolidated EntityBenzinga Newsdesk - Mar 6, 2024, 7:32AM
Monday, February 26, 2024
Tuesday, February 13, 2024
Thursday, January 25, 2024
Thursday, January 04, 2024
Wednesday, November 29, 2023
- Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Nov 29, 2023, 2:02PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Nov 29, 2023, 12:31PM
- Why Is Bacterial Infection-Focused BiomX Stock Trading Lower Today?Vandana Singh - Nov 29, 2023, 12:00PM
- BiomX Announced Safety And Efficacy Results From Part 2 Of The Phase 1B/2A Trial Of BX004 For Chronic Pulmonary Infections Due To Pseudomonas Aeruginosa In Cystic Fibrosis Patients, Showing Clinically Meaningful Improvement In Pulmonary FunctionBenzinga Newsdesk - Nov 29, 2023, 6:33AM
Tuesday, November 14, 2023
- HC Wainwright & Co. Reiterates Buy on BiomX, Maintains $7 Price TargetBenzinga Newsdesk - Nov 14, 2023, 11:18AM
- BiomX Q3 EPS $(0.13) Up From $(0.23) YoY; Cash Balance, Short-term Deposits And Restricted Cash Of $23.4M Is Estimated To Be Sufficient To Fund Operations Into The Third Quarter Of 2024Benzinga Newsdesk - Nov 14, 2023, 6:40AM
Wednesday, November 01, 2023
- Chief Business Officer at BiomX Exercises Options Worth $86KBenzinga Insights - Nov 1, 2023, 11:01AM
- Chief Financial Officer at BiomX Acquires Company Stock Options Worth 59,800 SharesBenzinga Insights - Nov 1, 2023, 11:01AM
- BiomX Chief Development Officer Acquires 189,997 Shares After Exercising Company Stock OptionsBenzinga Insights - Nov 1, 2023, 11:01AM
- Chief Executive Officer at BiomX Exercises Options Worth $204KBenzinga Insights - Nov 1, 2023, 11:01AM
Tuesday, October 24, 2023
Wednesday, October 04, 2023
Friday, August 11, 2023
Wednesday, August 09, 2023
- HC Wainwright & Co. Reiterates Buy on BiomX, Maintains $7 Price TargetBenzinga Newsdesk - Aug 9, 2023, 10:35AM
- BiomX Estimates Its Cash Runway To Be Sufficient To Fund Operations In Q3Benzinga Newsdesk - Aug 9, 2023, 6:37AM
- BiomX Q2 EPS $(0.12) Up From $(0.25) YoYBenzinga Newsdesk - Aug 9, 2023, 6:33AM
- Earnings Scheduled For August 9, 2023Benzinga Insights - Aug 9, 2023, 4:54AM